Cargando…

In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species

Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdil...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwarz, Patrick, Nikolskiy, Ilya, Bidaud, Anne-Laure, Sommer, Frank, Bange, Gert, Dannaoui, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100415/
https://www.ncbi.nlm.nih.gov/pubmed/35573795
http://dx.doi.org/10.3389/fcimb.2022.892893
_version_ 1784706846567694336
author Schwarz, Patrick
Nikolskiy, Ilya
Bidaud, Anne-Laure
Sommer, Frank
Bange, Gert
Dannaoui, Eric
author_facet Schwarz, Patrick
Nikolskiy, Ilya
Bidaud, Anne-Laure
Sommer, Frank
Bange, Gert
Dannaoui, Eric
author_sort Schwarz, Patrick
collection PubMed
description Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology for antifungal susceptibility testing. Results were analyzed with the fractional inhibitory concentration index and by the response surface analysis. Interpretation by the fractional inhibitory concentration index showed synergy for 50%, 80%, 90%, and 90% of the C. kefyr, C. krusei, C. glabrata, and C. tropicalis strains, respectively. Combination of isavuconazole with colistin against C. albicans and C. parapsilosis exhibited only indifference for 100% and 90% of the strains, respectively. The results were confirmed by response surface analysis for all species except for C. glabrata, for which an indifferent interaction was found for the majority of strains. Antagonistic interaction was never seen regardless of the interpretation model was used.
format Online
Article
Text
id pubmed-9100415
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91004152022-05-14 In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species Schwarz, Patrick Nikolskiy, Ilya Bidaud, Anne-Laure Sommer, Frank Bange, Gert Dannaoui, Eric Front Cell Infect Microbiol Cellular and Infection Microbiology Interactions of isavuconazole and colistin were evaluated against 57 common Candida strains belonging to the species Candida albicans (n = 10), Candida glabrata (n = 10), Candida kefyr (n = 8), Candida krusei (n = 10), Candida parapsilosis (n = 9), and Candida tropicalis (n = 10) by a broth microdilution checkerboard technique based on the European Committee on Antimicrobial Susceptibility Testing (EUCAST) reference methodology for antifungal susceptibility testing. Results were analyzed with the fractional inhibitory concentration index and by the response surface analysis. Interpretation by the fractional inhibitory concentration index showed synergy for 50%, 80%, 90%, and 90% of the C. kefyr, C. krusei, C. glabrata, and C. tropicalis strains, respectively. Combination of isavuconazole with colistin against C. albicans and C. parapsilosis exhibited only indifference for 100% and 90% of the strains, respectively. The results were confirmed by response surface analysis for all species except for C. glabrata, for which an indifferent interaction was found for the majority of strains. Antagonistic interaction was never seen regardless of the interpretation model was used. Frontiers Media S.A. 2022-04-29 /pmc/articles/PMC9100415/ /pubmed/35573795 http://dx.doi.org/10.3389/fcimb.2022.892893 Text en Copyright © 2022 Schwarz, Nikolskiy, Bidaud, Sommer, Bange and Dannaoui https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cellular and Infection Microbiology
Schwarz, Patrick
Nikolskiy, Ilya
Bidaud, Anne-Laure
Sommer, Frank
Bange, Gert
Dannaoui, Eric
In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title_full In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title_fullStr In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title_full_unstemmed In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title_short In Vitro Synergy of Isavuconazole Combined With Colistin Against Common Candida Species
title_sort in vitro synergy of isavuconazole combined with colistin against common candida species
topic Cellular and Infection Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100415/
https://www.ncbi.nlm.nih.gov/pubmed/35573795
http://dx.doi.org/10.3389/fcimb.2022.892893
work_keys_str_mv AT schwarzpatrick invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies
AT nikolskiyilya invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies
AT bidaudannelaure invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies
AT sommerfrank invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies
AT bangegert invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies
AT dannaouieric invitrosynergyofisavuconazolecombinedwithcolistinagainstcommoncandidaspecies